These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6556071)

  • 1. Interaction of human plasma kallikrein and its light chain with C1 inhibitor.
    van der Graaf F; Koedam JA; Griffin JH; Bouma BN
    Biochemistry; 1983 Sep; 22(20):4860-6. PubMed ID: 6556071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of kallikrein in human plasma.
    van der Graaf F; Koedam JA; Bouma BN
    J Clin Invest; 1983 Jan; 71(1):149-58. PubMed ID: 6184384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen.
    Schapira M; Scott CF; Colman RW
    Biochemistry; 1981 May; 20(10):2738-43. PubMed ID: 6910423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of human plasma kallikrein and its light chain with alpha 2-macroglobulin.
    van der Graaf F; Rietveld A; Keus FJ; Bouma BN
    Biochemistry; 1984 Apr; 23(8):1760-6. PubMed ID: 6202319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein.
    Olson ST; Sheffer R; Francis AM
    Biochemistry; 1993 Nov; 32(45):12136-47. PubMed ID: 7692967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrolysis of human high-molecular-mass kininogen by human plasma kallikrein. Proposal of a new model concept for the course of reaction in presence and absence of C1(-)-inhibitor.
    Wiedler J; Dutler H
    Biol Chem Hoppe Seyler; 1987 Sep; 368(9):1203-13. PubMed ID: 3675872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the effect of high molecular weight kininogen upon the fluid-phase inactivation of kallikrein by C1 inhibitor.
    Silverberg M; Longo J; Kaplan AP
    J Biol Chem; 1986 Nov; 261(32):14965-8. PubMed ID: 3639874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of plasma kallikrein and C1-s with normal and dysfunctional C1(-)-inhibitor proteins from patients with hereditary angioneurotic edema: analytic gel studies.
    Donaldson VH; Wagner CJ; Tsuei B; Kindness G; Bing DH; Harrison RA; Rosen FS
    Blood; 1987 Apr; 69(4):1096-101. PubMed ID: 3493816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human blood coagulation factor XIa by C-1 inhibitor.
    Meijers JC; Vlooswijk RA; Bouma BN
    Biochemistry; 1988 Feb; 27(3):959-63. PubMed ID: 3259145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parallel mechanisms of high molecular weight kininogen action as a cofactor in kallikrein inactivation and prekallikrein activation reactions.
    Olson ST; Francis AM; Sheffer R; Choay J
    Biochemistry; 1993 Nov; 32(45):12148-59. PubMed ID: 8218292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of plasma kallikrein by C1-inhibitor: role of endothelial cells and the amino-terminal domain of C1-inhibitor.
    Ravindran S; Grys TE; Welch RA; Schapira M; Patston PA
    Thromb Haemost; 2004 Dec; 92(6):1277-83. PubMed ID: 15583734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cleavage of the heavy chain of human plasma kallikrein on its functional properties.
    Colman RW; Wachtfogel YT; Kucich U; Weinbaum G; Hahn S; Pixley RA; Scott CF; de Agostini A; Burger D; Schapira M
    Blood; 1985 Feb; 65(2):311-8. PubMed ID: 3871342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complexes between C1-inhibitor, kallikrein, high molecular weight kininogen, plasma thromboplastin antecedent, and plasmin in normal human plasma and hereditary angioneurotic edema plasmas containing dysmorphic C1-inhibitors: role of cold activation.
    Donaldson VH; Harrison RA
    Blood; 1982 Jul; 60(1):121-9. PubMed ID: 6211203
    [No Abstract]   [Full Text] [Related]  

  • 14. Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma.
    Schapira M; Scott CF; Colman RW
    J Clin Invest; 1982 Feb; 69(2):462-8. PubMed ID: 6173399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human high molecular weight kininogen as a thiol proteinase inhibitor: presence of the entire inhibition capacity in the native form of heavy chain.
    Higashiyama S; Ohkubo I; Ishiguro H; Kunimatsu M; Sawaki K; Sasaki M
    Biochemistry; 1986 Apr; 25(7):1669-75. PubMed ID: 3635411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-protein interactions in contact activation of blood coagulation. Binding of high molecular weight kininogen and the 5-(iodoacetamido) fluorescein-labeled kininogen light chain to prekallikrein, kallikrein, and the separated kallikrein heavy and light chains.
    Bock PE; Shore JD; Tans G; Griffin JH
    J Biol Chem; 1985 Oct; 260(23):12434-43. PubMed ID: 3850090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New and rapid functional assay for C1 inhibitor in human plasma.
    Schapira M; Silver LD; Scott CF; Colman RW
    Blood; 1982 Apr; 59(4):719-24. PubMed ID: 6174161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human plasma kallikrein and C1 inhibitor form a complex possessing an epitope that is not detectable on the parent molecules: demonstration using a monoclonal antibody.
    de Agostini A; Schapira M; Wachtfogel YT; Colman RW; Carrel S
    Proc Natl Acad Sci U S A; 1985 Aug; 82(15):5190-3. PubMed ID: 2410915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunochemical studies of human high molecular weight kininogen and of its complexes with plasma prekallikrein or kallikrein.
    Kerbiriou DM; Bouma BN; Griffin JH
    J Biol Chem; 1980 May; 255(9):3952-8. PubMed ID: 6154706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and functional properties of the heavy and light chains of human plasma kallikrein.
    van der Graaf F; Tans G; Bouma BN; Griffin JH
    J Biol Chem; 1982 Dec; 257(23):14300-5. PubMed ID: 6815193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.